Backs FY25 adjusted EBITDA view $150M-$160M. Backs FY25 free cash flow $85M-$95M. “In light of the macro uncertainty and the prospect of lower economic growth resulting from tariffs or other geopolitical events, we maintain a cautious tone,” concluded Sternlieb. “Nonetheless, given our growth through the first half of fiscal 2025, we are reiterating full-year guidance, including sales and adjusted EBITDA growth of 5 percent at the midpoint.”